Effects of puerarin on protein expression of protein kinase B in adipose tissue of rats fed by high-fat-diet

Abstract

Abstract: AIM: To study the effects of puerarin on protein expression of protein kinase B (PKB) in adipose tissue of rats fed by high-fat-diet.METHODS: 30 male Wistar rats were randomly divided into the control group(n=10) given basic diet, and the model group (n=20) given fat-rich-diet.After 4 weeks, the model group was randomly divided into 2 subgroups :(1) insulin resistant group was continually given high fat-rich-diet ;(2) puerarin-treated group accepted high-fat diet and abdominal injection with puerarin injection (100 mg·kg^-1·d^-1).After 6 week- treatment, the protein expression of PKB stimulated by insulin in adipose tissue was determined with Western blotting at the end of the experiment.RESULTS: The model group showed hyperglycemia, hyperinsulinism, hypertriglyceride, hypercholesterolemia and elevated HOMA insulin resistance index (HOMAIR), while the insulin resistance index (ISI) was obviously reduced compared to the control group, indicating that the insulin resistant model was induced in this way.Puerarin treatment decreased fasting blood glucose and insulin, which was accompanied by lower HOMA-IR and elevated ISI.Because of long term high fat diet, expression of PKB decreased 23.5 %in adipose tissue of the insulin resistant group(P<0.01) compare with the control group.There was an increase of 18.7 %(P<0.01) in PKB expression of the puerarin-treated group compared to the insulin resistant group.CONCLUSION: Puerarin treatment can significantly elevate expression of PKB and ameliorated the stated of insulin resistance.

Key words: puerarin, insulin resistance, adipose tissue, PKB, expression

CLC Number:

R285.

LI Jian-Hui, BI Hui-Min, GAN Pei-Zhen, WANG Bao-Hua. Effects of puerarin on protein expression of protein kinase B in adipose tissue of rats fed by high-fat-diet[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(7): 770-773.

References

1 Whiteman EL, Cho H, Birnbaum MJ.Role of Akt protein kinase B in metabolism[J].Trends Endocrinol Metab, 2002;13(10):444-51
2 朱庆磊, 吕欣然.葛根素的药理学和临床应用研究进展 [J].中草药, 1997;28(11):661-6
3 Schwartz RS, Brunzell JD.Increase of adipose tissue lipoprotein lipase activity with weight loss[J].J Clin Invest, 1981;67(5): 1425-30
4 刘蕴玲, 陈少华, 陈秀彬.葛根素对Ⅱ 型糖尿病病人胰岛素敏感性的影响[J].辽宁食用糖尿病杂志, 2000;8(1): 26-8
5 段有金, 王韶颍, 三轮一智, 奥田润.五种中药对蛋白质非酶糖基化的压制作用[J].中国糖尿病杂志, 1998;6(4):227-9
6 Hajduch E, Llither land GL, Hundal HS.Protein kinase B (PKB Akt)-a key regulator of glucose transport[J].FRBS Letters, 2001;492(3):199-203
7 Garofalo RS, Orena SJ, Rafidi K, Torchia AJ, Stocl JL, Hildebrandt AL, et al.Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2 PKB[J].J Clin Invest, 2003;112(2):197-208
8 Buren J, Liu HX, Jensel J, Eriksson JW.Dexamethasone impairs insulin signaling and glucose transport by depletion of insulin receptor substrate-1.phosphatidylinositol 3-kinase and protein kinase B in primary cultured rat adipocytes[J].Eur J Endocrine, 2002;146(3):419-29
9 Kim YB, Peroni OD, Franke TF, Kahn BB.Divergent regulation of Akt1 and Akt2 isoforms in insulin target of obese Zucker rats[J].Diabetes, 2000;49(5):847-56
10 Tremblav F, Lavigne C, Jacques H, Marette A.Dietary cod protein restores insulin-induced activation of phosphatidylinositol 3-kinase Akt and Glut4 translocation to T-tubules in skeletal muscle of high fat-fed obese rats[J].Diabetes, 2003;52(1): 29-37
11 Kausch C, Krutzfeldt J, Witke A, Rettig A, Bachmann O, Rett K, et al.Effects of troglitazone on celluar differentiation, insulin signaling and glucose metabolism in cultured human skeletal muscle cells [J].Biochem Biophys Res Commun, 2001;280(3):264-7
12 Schmitz Peiffer C.Signaling aspects of insulin resistance in skeletal muscle:metabolisms induced by lipid oversupply[J].Celluar Signaling, 2000;12(9-10):583-94
13 Ruan H, Hacohen N, Golub TR, Van Parijs L, Lodish HF. Tumor necrosis factor-alpha suppresses adipocyte-specific genes and activates expression of preadipocyte genes in 3T3-L1 adipocytes: nuclear factor-kappaB activation by TNF-alpha is obligatory[J].Diabetes, 2002;51(5):1319-36

[1]	QUAN Haiyan, JIANG Xing, HE Lu. Recent progress of mitophagy in hepatic insulin resistance [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(2): 198-204.
[2]	ZHANG Yu, PENG Ying, WANG Guangji, SUN Jianguo. Advances in study of phase II metabolic enzyme expression and activity under diseases status [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(6): 686-700.
[3]	QUAN Haiyan, LIU Yuhuan, YANG Li, YANG Fang, QIN Xuping. Improvement of CGRP on vascular endothelial cells insulin resistance via activation of cAMP/PPARγ/eNOS pathway [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(6): 615-622.
[4]	GUO Liangtang, LIN Chao, SUN Yun, DAI Shengfeng, ZHANG Bingcai, CHEN Shu. Effects of metformin on patients with polycystic ovary syndrome and its effect on adipose tissue miR-25 level [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(5): 554-560.
[5]	DING Fan, LI Wenxiong, ZHANG Jiali, ZHANG Yan. Research progress on pathology mechanism and treatment target for diabetic sarcopenia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(12): 1428-1433.
[6]	ZHENG Li, MO Juanfen, WU Jiayuan, GUO Li, BAO Yi. Study on the anti-hyperlipidemia mechanisms and signaling pathways of traditional Chinese medicine Polygonum cuspidatum based on network pharmacology [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2019, 24(10): 1107-1119.
[7]	ZHANG Qian, FU Hong, CHEN Jinjin, ZHU Yubing. Research progress of IL33/ST2 in acute coronary syndrome [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1075-1080.
[8]	DONG Xiaojie, WU Yujing, ZHANG Jing, CHEN Wensheng, HUANG Qiong, WEI Wei. Effects of IgD on the balance of Th1/Th2 and Th17/Treg subsets and transcription factors expression in human peripheral blood [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 488-497.
[9]	ZHANG Yiwen, LOU Qianwen, ZHONG Like, PAN Zongfu, FANG Luo, HUANG Ping. Study on the differences gene between proximal and distal colon cancer based on GEO database by bioinformatics [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(4): 422-427.
[10]	LI Xi, JIN Gaofeng, LIU Zhijun, LI Xinhua, LIU Mingyi, ZHANG Hong, XIONG Yuqing. Relevance of plasma distribution of microRNA-148a in Chinese population and hyperlipidemia [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 659-663.
[11]	SONG Meiqing. Effect of metformin on bone mineral density, insulin resistance and cytokines in type 2 diabetes mellitus patients with primary hypertension [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(6): 694-698.
[12]	SHEN Ji-zhong, LIU Hang. Experimental study of a metabolic syndrome mouse model induced by high sucrose-containing drinking water [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(9): 1011-1015.
[13]	ZOU Liu-yi, WANG Mei-rong, NI Lian-song. Effects of ketotifen on insulin resistance in high-carbon hydrate-fat diet rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(7): 761-765.
[14]	WANG Jin-ping, LI Wen, CHEN Jia-yi, LI Lu. Effect of xuebijing injection on liver gene expression of NF-κB in septic rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(4): 385-388.
[15]	JIN Wan-bing. Protective effects of puerarin on gentamicin-induced nephrotoxicity in rats [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(8): 864-867.